[HTML][HTML] Гипертрофическая кардиомиопатия. Клинические рекомендации 2020
СА Габрусенко, АЯ Гудкова… - Российский …, 2021 - cyberleninka.ru
Члены Рабочей группы подтвердили отсутствие финансовой поддержки/конфликта
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
интересов. В случае сообщения о наличии конфликта интересов, член (ы) Рабочей …
Гипертрофическая кардиомиопатия: современное состояние проблемы (по материалам сообщения Международного комитета экспертов по ГКМП)
СА Габрусенко - Consilium medicum, 2004 - elibrary.ru
Гипертрофическая кардиомиопатия (ГКМП)-одна из основных и, вероятно, наиболее
распространенных форм кардиомиопатий, заболеваний миокарда, сопровождающихся …
распространенных форм кардиомиопатий, заболеваний миокарда, сопровождающихся …
Гипертрофическая кардиомиопатия: генетические изменения, патогенез и патофизиология
НТ Ватутин, ГГ Тарадин, МС Марон - Российский …, 2014 - cyberleninka.ru
Настоящий обзор посвящен описанию генетических изменений, патогенетических
механизмов и патофизиологии гипертрофической кардиомиопатии на основе анализа …
механизмов и патофизиологии гипертрофической кардиомиопатии на основе анализа …
Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment
DL Jacoby, EC DePasquale, WJ McKenna - CMAJ, 2013 - Can Med Assoc
We performed a PubMed search using the term “hypertrophic cardiomyopathy.” We
reviewed all articles published between Jan. 1, 2005, and May 1, 2012, for relevance. We …
reviewed all articles published between Jan. 1, 2005, and May 1, 2012, for relevance. We …
[HTML][HTML] 2020 Clinical practice guidelines for Hypertrophic cardiomyopathy
SA Gabrusenko, AY Gudkova… - Russian Journal of …, 2021 - russjcardiol.elpub.ru
: hypertrophic cardiomyopathy, obstructive hypertrophic cardiomyopathy, hypertrophic
cardiomyopathy phenocopies, sarcomeric mutations, familial genetic screening, sudden …
cardiomyopathy phenocopies, sarcomeric mutations, familial genetic screening, sudden …
Current state of hypertrophic cardiomyopathy clinical trials
Background Hypertrophic cardiomyopathy (HCM) is a genetic disorder with a very large
global burden for which more therapeutic management regimens are required. Objectives In …
global burden for which more therapeutic management regimens are required. Objectives In …
Hypertrophic cardiomyopathy in 2012
CY Ho - Circulation, 2012 - Am Heart Assoc
Background Hypertrophic cardiomyopathy (HCM) is an intrinsic myocardial disorder
characterized by unexplained left ventricular hypertrophy (LVH) that occurs in the absence …
characterized by unexplained left ventricular hypertrophy (LVH) that occurs in the absence …
Update on hypertrophic cardiomyopathy and a guide to the guidelines
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder,
affecting 1 in 500 individuals worldwide. Existing epidemiological studies might have …
affecting 1 in 500 individuals worldwide. Existing epidemiological studies might have …
Hypertrophic cardiomyopathy: a practical approach to guideline directed management
SR Ommen, C Semsarian - The Lancet, 2021 - thelancet.com
Hypertrophic cardiomyopathy, one of the most common genetic cardiovascular conditions,
will be encountered by nearly every health-care provider regardless of specialty. In 2020 …
will be encountered by nearly every health-care provider regardless of specialty. In 2020 …
Guidelines for Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy (JCS 2012)–Digest Version–
JCS Joint Working Group - Circulation Journal, 2016 - jstage.jst.go.jp
754 JCS Joint Working Group guidelines useful in clinical practice. We hope these
guidelines will help clinicians treat patients with HCM. In this document, recommendations …
guidelines will help clinicians treat patients with HCM. In this document, recommendations …